Skip to main content

Acute Thyroid and Adrenal Disorders

  • Chapter
  • First Online:
Clinical Pathways in Emergency Medicine

Abstract

Acute thyroid disorders are infrequently observed in clinical practice with a poorly defined incidence. They represent a long-standing dysregulation of thyroid gland, usually precipitated by an acute illness. They are either caused by overt dysfunction resulting in myxoedema coma or hyperfunctioning of the gland giving rise to thyrotoxicosis. Despite utmost care, mortality remains high, 30–50 % in myxoedema coma and 30–40 % in thyroid storm thereby necessitating immediate and aggressive intervention in emergency department.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 199.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 249.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Gavin LA. Thyroid crises. Med Clin N Am. 1991;75:179–93.

    Article  CAS  PubMed  Google Scholar 

  2. Tietgens ST, Leinung MC. Thyroid storm. Med Clin N Am. 1995;79:169–84.

    Article  CAS  PubMed  Google Scholar 

  3. Wartofsky L. Thyrotoxic storm. In: Braverman L, Utiger R, editors. Werner & Ingbar’s the thyroid. 9th ed. Philadelphia: Williams & Wilkins; 2005. p. 651–7.

    Google Scholar 

  4. Klein I, Danzi S. Thyroid disease and the heart. Circulation. 2007;116:1725–35.

    Article  PubMed  Google Scholar 

  5. Burch HB, Wartofsky L. Life-threatening thyrotoxicosis. Thyroid storm. Endocrinol Metab Clin N Am. 1993;22(2):263–77.

    CAS  Google Scholar 

  6. Akin F, Yaylali GF, Bastemir M. The use of lithium carbonate in the preparation for definitive therapy in hyperthyroid patients. Med Princ Pract. 2008;17(2):167.

    Article  PubMed  Google Scholar 

  7. Wartofsky L. Thyrotoxic storm. In: Braverman LE, Utiger RD, editors. Werner’s & Ingbar’s the thyroid, 9th ed. Philadelphia: Lippincott Williams and Wilkins; 2005.

    Google Scholar 

  8. Rodríguez I, Fluiters E, Pérez-Méndez LF, Luna R, Páramo C, García-Mayor RV. Factors associated with mortality of patients with myxoedema coma: prospective study in 11 cases treated in a single institution. J Endocrinol. 2004;180(2):347–50.

    Article  PubMed  Google Scholar 

  9. Dutta P, Bhansali A, Masoodi S, Bhadada S, Sharma N, Rajput R. Predictors of outcome in myxoedema coma: a study from a tertiary care centre. Crit Care. 2008;12(1):R1.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Braverman LE, Utiger RD, editors. Werner and Ingbar’s the thyroid. 8th ed. Philadelphia: Lippincott, Williams and Wilkins; 2000. p. 1081.

    Google Scholar 

  11. Ladenson PW, Goldenheim PD, Ridgway EC. Prediction and reversal of blunted ventilatory responsiveness in patients with hypothyroidism. Am J Med. 1988;84(5):877–83.

    Article  CAS  PubMed  Google Scholar 

  12. Wilson WR, Bedell GN. The pulmonary abnormalities in myxedema. J Clin Invest. 1960;39:42–55.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Massumi RA, Winnacker JL. Severe depression of the respiratory center in myxedema. Am J Med. 1964;36(6):876–82.

    Article  CAS  PubMed  Google Scholar 

  14. Reinhardt W, Mann K. Incidence, clinical picture, and treatment of hypothyroid coma: results of a survey. Med Klin. 1997;92:521–4.

    Article  CAS  Google Scholar 

  15. Purnell JQ, Brandon DD, Isabelle LM, Loriaux DL, Samuels MH. Association of 24-hour cortisol production rates, cortisol-binding globulin, and plasma-free cortisol levels with body composition, leptin levels, and aging in adult men and women. J Clin Endocrinol Metab. 2004;89:281–7.

    Article  CAS  PubMed  Google Scholar 

  16. Bansal V, Asmar NE, Selman WR, Arafah BM. Pitfalls in the diagnosis and management of Cushing’s syndrome. Neurosurg Focus. 2015;38(2), E4.

    Article  PubMed  Google Scholar 

  17. Ragnarsson O, Johannsson G. Cushing’s syndrome: a structured short- and long-term management plan for patients in remission. Eur J Endocrinol. 2013;169:R139–52.

    Article  CAS  PubMed  Google Scholar 

  18. Newell-Price J, Bertagna X, Grossman AB, Nieman LK. Cushing’s syndrome. Lancet. 2006;367:1605–17.

    Article  CAS  PubMed  Google Scholar 

  19. Van der Pas R, Leebeek FW, Hofland LJ, de Herder WW, Feelders RA. Hypercoagulability in Cushing’s syndrome: prevalence, pathogenesis and treatment. Clin Endocrinol (Oxf) 2013;78:481–88. Fernández-Rodríguez E, et al. Severe hypertension and hypokalemia as first clinical manifestations in ectopic Cushing’s syndrome. Endocrinol Metabol. 2008;52(6):1066–70.

    Google Scholar 

  20. Soh LM, Gunganah K, Akker SA, Jones P, Khachi H, Dodzo K, Drake WM. Etomidate in the emergency management of hypercortisolemia. Eur J Endocrinol. 2012;167(5):727–8.

    Article  CAS  PubMed  Google Scholar 

  21. Colao A, Petersenn S, et al. A 12-month phase 3 study of pasireotide in Cushing’s disease. N Engl J Med. 2012;366:914–24.

    Article  CAS  PubMed  Google Scholar 

  22. Nieman LK. Update in the medical therapy of Cushing’s disease. Curr Opin Endocrinol Diabetes Obes. 2013;20:330–4.

    CAS  PubMed  PubMed Central  Google Scholar 

  23. Pasini B, Stratakis CA. SDH mutations in tumorigenesis and inherited endocrine tumours: lesson from the phaeochromocytoma–paraganglioma syndromes. J Intern Med. 2009;266:19–42.

    Article  CAS  PubMed  Google Scholar 

  24. Manger W, Gifford RJ. Pheochromocytoma: a clinical review. In: Laragh J, Brenner B, editors. Hypertension: pathophysiology, diagnosis, and management, vol. 2. 2nd ed. New York: Raven Press; 1995. p. 2225–44.

    Google Scholar 

  25. Mazzaglia PJ. Hereditary pheochromocytoma and paraganglioma. J Surg Oncol. 2012;106:580–5.

    Article  CAS  PubMed  Google Scholar 

  26. Canu L, Rapizzi E, Zampetti B, et al. Pitfalls in genetic analysis of pheochromocytomas/paragangliomas – case report. J Clin Endocrinol Metab. 2014;99:2321–6.

    Article  CAS  PubMed  Google Scholar 

  27. Mariucci VL, Pacak K. Pheochromocytoma and paraganglioma: diagnosis, genetics, management, and treatment. Curr Probl Cancer. 2014;38:7–41.

    Article  Google Scholar 

  28. Barontini M, Levin G, Sanso G. Characteristics of pheochromocytoma in a 4- to 20-year-old population. Ann N Y Acad Sci. 2006;1073:30–7.

    Article  PubMed  Google Scholar 

  29. Sloand EM, Thompson BT. Propranolol-induced pulmonary edema and shock in a patient with pheochromocytoma. Arch Intern Med. 1984;144:173–4.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to P. E. Rama Subrahmanyam MBBS, FAEM, MCEM .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer India

About this chapter

Cite this chapter

Subrahmanyam, P.E.R. (2016). Acute Thyroid and Adrenal Disorders. In: David, S. (eds) Clinical Pathways in Emergency Medicine. Springer, New Delhi. https://doi.org/10.1007/978-81-322-2710-6_31

Download citation

  • DOI: https://doi.org/10.1007/978-81-322-2710-6_31

  • Published:

  • Publisher Name: Springer, New Delhi

  • Print ISBN: 978-81-322-2708-3

  • Online ISBN: 978-81-322-2710-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics